Abstract
This literature review aims to investigate contemporary strategies for the secondary prevention of Pulmonary Embolism (PE). The research encompassed recent studies, focusing on anticoagulation, including novel oral anticoagulants, surgical interventions, and advanced diagnostic methods. Emphasizing the importance of personalized treatment considering individual factors, the review underscores the need for additional studies to validate conclusions and inform more robust clinical guidelines. This review contributes to an in-depth understanding of secondary prevention strategies for PE, highlighting the integrated and personalized approach as crucial for optimizing clinical outcomes and reducing PE recurrence.
References
Goldhaber SZ, Morrison RB. "Epidemiology and Risk Factors for Pulmonary Embolism: An Update." Circulation. 2020;141(5):418-422.
Wells PS, Stevens P, Kearon C. "Thrombosis in patients with COVID-19: updates from the International Society on Thrombosis and Hemostasis (ISTH)." Journal of Thrombosis and Haemostasis. 2019;17(11):3265-3270.
Konstantinides SV, Meyer G, Becattini C. "2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)." European Heart Journal. 2021;42(14): 1596-1667.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2024 José Lucas Moura Vasconcelos, Amanda Custódio Silva , Ana Luiza Gomes Gonçalves, Dolores Tavares, Gabriella Gamoski Maccare, Gilmara Gabrielli Gregory , Giordana Gregório Fritsch, Ingryd de Almeida Silva, Izabella Gonzaga Gaspar, Lucas de Lima Zaias , João Paulo Cunha Lima , Júlia Assunção Freire , Juliana Nogueira Leal de Moraes , Kahysa Magalhães de Oliveira , Marcela Bringel Franco, Matheus Rafael Bueno Teixeira , Nara Lis Freire Benigno, Rafaela Bollini Polycarpo , Sâmila Rinna Rêgo Lira, Sarah Geia Yaktine , Susan Nundes Lindote, Thauana Santana de Sá